Goldman Sachs Maintains Buy on Tenet Healthcare, Raises Price Target to $98
Portfolio Pulse from Benzinga Newsdesk
Goldman Sachs analyst Jamie Perse maintains a Buy rating on Tenet Healthcare (NYSE:THC) and raises the price target from $89 to $98.
August 14, 2023 | 12:22 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Goldman Sachs maintains a Buy rating on Tenet Healthcare and raises the price target from $89 to $98. This could potentially lead to an increase in the stock's price.
The raised price target by Goldman Sachs indicates a positive outlook for Tenet Healthcare. This could lead to increased investor confidence and potentially drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100